Latest Articles about COV

Positive Data for COV's Solitaire - Analyst Blog

Zacks Equity Research — Mon, 17 Jun 2013 21:25:01 Z

International health care products major, Covidien plc ( COV ) presented encouraging data at the 2013 European Stroke Conference regarding the superiority of its endovascular offering,

Bear of the Day: Covidien (COV) - Bear of the Day

Kevin Cook — Wed, 12 Jun 2013 13:02:01 Z

In the wake of its dismal fiscal 2013 second quarter results, analysts covering Covidien PLC ( COV ), the $30 billion medical products maker, slashed earnings estimates for both this year and

Masimo Wins a Major Client - Analyst Blog

Zacks Equity Research — Mon, 10 Jun 2013 23:28:09 Z

Masimo Corporation ( MASI ), a leader in non-invasive monitoring technology for patient care, together with University Children's Hospital Basel in Basel, Switzerland, recently reported

STJ Begins U.S. Trial for EnligHTN - Analyst Blog

Zacks Equity Research — Wed, 05 Jun 2013 17:29:31 Z

For the first time, St. Jude Medical Inc. ( STJ ) has won the U.S. Food and Drug Administration's (FDA) approval to commence the EnligHTN IV trial. The study will evaluate the efficacy of

Baxter International Inc. (BAX) Ex-Dividend Date Scheduled for June 05, 2013

NASDAQ.com News — Tue, 04 Jun 2013 17:00:04 Z

Baxter International Inc. ( BAX ) will begin trading ex-dividend on June 05, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on July 01, 2013. Shareholders who

COV Begins Nellcor Labeling Process - Analyst Blog

Zacks Equity Research — Sat, 01 Jun 2013 03:26:31 Z

International healthcare products major, Covidien plc ( COV ) has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for Critical Congenitial Heart

COV Progresses Further with Spin-Off - Analyst Blog

Zacks Equity Research — Thu, 30 May 2013 18:29:07 Z

Covidien plc ( COV ) has moved a step further with the decision to divest its Pharmaceuticals business, Mallinckrodt. Covidien's board of directors has given a green signal for the

A Major User of Masimo Expertise - Analyst Blog

Zacks Equity Research — Wed, 29 May 2013 22:25:50 Z

Masimo Corporation ( MASI ), a leader in non-invasive monitoring technology for patient care, recently reported that El Paso Children's Hospital, a prominent children's hospital in the

Covidien Downgraded to Underperform - Analyst Blog

Zacks Equity Research — Tue, 28 May 2013 22:28:21 Z

On May 27, we downgraded medical device company, Covidien plc. ( COV ) to Underperform based on the company's disappointing outlook for 2013. Why the Downgrade? Estimates for Covidien

St. Jude Begins EnligHTNment Study - Analyst Blog

Zacks Equity Research — Fri, 24 May 2013 23:28:35 Z

St. Jude Medical Inc. ( STJ ) commenced the EnligHTNment trial study at the EuroPCR to analyze the effectiveness of its EnligHTN Multi-Electrode Renal Denervation System in reducing major

Covidien's ENB Adopted by ACCP - Analyst Blog

Zacks Equity Research — Thu, 23 May 2013 19:30:09 Z

Covidien plc ( COV ) revealed that the American College of Chest Physicians (ACCP) has included the company's superDimension Electromagnetic Navigation Bronchoscopy (ENB) system in its

FDA Nod for COV's Advanced Nellcor - Analyst Blog

Zacks Equity Research — Tue, 21 May 2013 18:29:13 Z

International health care products major, Covidien plc ( COV ) has won the approval of the U.S. Food and Drug Administration ("FDA") for its motion-tolerant Nellcor pulse oximetry

3M Company (MMM) Ex-Dividend Date Scheduled for May 22, 2013

NASDAQ.com News — Tue, 21 May 2013 17:00:03 Z

3M Company ( MMM ) will begin trading ex-dividend on May 22, 2013. A cash dividend payment of $0.635 per share is scheduled to be paid on June 12, 2013. Shareholders who purchased MMM stock

Covidien Prices Senior Notes - Analyst Blog

Zacks Equity Research — Thu, 16 May 2013 17:29:17 Z

Healthcare major, Covidien plc ( COV ) announced that its fully-owned subsidiary Covidien International Finance S.A. (CIFSA) will be offering 2.950% underwritten senior notes due 2023 for

MedTech Industry Stock Update - May 2013 - Zacks Analyst Interviews

Zacks Equity Research — Wed, 15 May 2013 11:38:01 Z

As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the much-hyped takeover battle for Life Technologies Corporation ( LIFE ) came to an end last